44 results match your criteria: "Fangshan Hospital Beijing University of Chinese Medicine[Affiliation]"
Oncol Rep
February 2025
Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
Targeted drugs have revolutionized the treatment of advanced non‑small cell lung cancer (NSCLC). However, the understanding of how cardiac comorbidity and toxicity affect the clinical outcomes of patients following targeted therapy remains limited. In a 14‑year cohort, cardiac comorbidities and toxicities among patients with stage‑IV NSCLC treated with targeted therapy were identified.
View Article and Find Full Text PDFCurr Probl Cardiol
December 2024
Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing University of Chinese Medicine, Beijing, China; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China; College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China. Electronic address:
Mol Cell Biochem
November 2024
Fangshan Hospital Beijing University of Chinese Medicine, Beijing, 102400, China.
Sci Rep
August 2024
Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Front Nutr
July 2024
Department of Nutrition, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Objective: This study aims to examine the nutritional status of individuals diagnosed with esophageal cancer and compare the nutritional indicators and intestinal flora between malnourished and non-malnourished patients. The findings aim to contribute to the early prevention of malnutrition and the development of interventions targeting the intestinal flora to treat esophageal cancer.
Methods: An 80-patient sample of hospitalized individuals with esophageal cancer was selected from the radiotherapy department of our hospital between July 2021 and July 2022 to evaluate NRS2002 scores and PG-SGA scores.
Arch Dermatol Res
July 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Int J Rheum Dis
June 2024
Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Dermatol Ther (Heidelb)
April 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Rheumatology (Oxford)
July 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Int J Rheum Dis
January 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Heliyon
November 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Objective: SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis) syndrome is a heterogeneous disease that clinically manifests as chronic inflammatory osteoarticular and dermatological lesions. Few reports have described familial clustering of SAPHO syndrome cases. This research aimed to illustrate the family aggregation of SAPHO syndrome and investigate the prevalence of autoimmune disorders among SAPHO syndrome patients and first-degree relatives in a large cohort.
View Article and Find Full Text PDFBackground: In the Qing dynasty, Yanghe decoction was as a therapeutic soup for effectively treating chronic inflammatory disorders. It was used as a therapeutic soup for effectively treating chronic inflammatory disorders. In the clinical use of Yanghe decoction, the adjustment of the medication for a variety of inflammatory diseases have therapeutic effect, including mastitis.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
October 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Secukinumab, a monoclonal antibody targeting interleukin-17 (IL-17), has exhibited encouraging results in the therapeutic management of palmoplantar pustulosis (PPP). The development of alopecia areata (AA) is closely related to IL-17, and IL-17A inhibitors were considered as a potential treatment modality. Therefore, the development of AA during secukinumab treatment for PPP is a rare adverse event that has been rarely reported worldwide.
View Article and Find Full Text PDFFront Cardiovasc Med
September 2023
China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beijing, China.
[This corrects the article DOI: 10.3389/fcvm.2023.
View Article and Find Full Text PDFInt J Rheum Dis
January 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is an uncommon clinical syndrome with the signs of skin problems and osteoarthropathy as its main features. The pathogenesis of SAPHO syndrome has not been fully elucidated, and multiple complications may be present, including thrombosis. A 39-year-old male patient was diagnosed with SAPHO syndrome, complicated by multiple venous thrombosis of the left lower limb.
View Article and Find Full Text PDFInt J Rheum Dis
December 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Clin Exp Rheumatol
January 2024
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Front Immunol
July 2023
Department of Rheumatology, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China.
Background And Aim: Rheumatoid arthritis (RA) is an autoinflammatory disease that may lead to severe disability. The diagnosis of RA is limited due to the need for biomarkers with both reliability and efficiency. Platelets are deeply involved in the pathogenesis of RA.
View Article and Find Full Text PDFInt J Rheum Dis
November 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Int J Rheum Dis
November 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoimmune inflammatory disease characterized by osteoarticular and dermatological manifestations. The most common osteoarticular manifestations involve the anterior chest wall, axial skeleton, and long bones. Cranial bone involvement is less reported in SAPHO syndrome.
View Article and Find Full Text PDFFront Cardiovasc Med
April 2023
China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beijing, China.
A variety of immune cell subsets occupy different niches in the cardiovascular system, causing changes in the structure and function of the heart and vascular system, and driving the progress of cardiovascular diseases (CVDs). The immune cells infiltrating the injury site are highly diverse and integrate into a broad dynamic immune network that controls the dynamic changes of CVDs. Due to technical limitations, the effects and molecular mechanisms of these dynamic immune networks on CVDs have not been fully revealed.
View Article and Find Full Text PDFJoint Bone Spine
September 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, 102401 Beijing, China. Electronic address:
Clin Cosmet Investig Dermatol
April 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, People's Republic of China.
Introduction: SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is a rare disease clinically characterized by a wide range of cutaneous and osteoarticular manifestations, involving multiple system impairments. Vasculitis is a rare comorbidity of SAPHO. Henoch-Schönlein purpura (HSP) is a vasculitis involving the capillaries and arterioles mediated by IgA immune complex.
View Article and Find Full Text PDFInt J Rheum Dis
October 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease. The main clinical manifestation of SAPHO syndrome is an osteoarthropathy with cutaneous involvement. Relapsing polychondritis (RP) characterized by chronic inflammation and cartilage degeneration is a rare systematic autoimmune disease.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
March 2023
Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, 102401, People's Republic of China.
SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome is a rare disease characterized by osteoarticular and cutaneous manifestations. SAPHO syndrome mostly involves the skin, mainly presented as palmoplantar pustulosis and severe acne. Sweet's syndrome (SS) is a neutrophilic dermatosis of unknown cause, which may be caused by autoinflammation.
View Article and Find Full Text PDF